Active Ingredient History
Esomeprazole, sold under the brand name Nexium [or Neksium] among others, is a medication which reduces stomach acid. It is used to treat gastroesophageal reflux disease, peptic ulcer disease, and Zollinger–Ellison syndrome. Its effectiveness is similar to that of other proton pump inhibitors (PPIs). It is taken by mouth or injection into a vein. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Abdominal Pain (Phase 4)
Achlorhydria (Phase 1)
Acute Coronary Syndrome (Phase 4)
Airway Management (Phase 3)
Anastomotic Leak (Phase 4)
Anti-Inflammatory Agents, Non-Steroidal (Phase 3)
Arthritis (Phase 3)
Arthritis, Juvenile (Phase 4)
Arthritis, Rheumatoid (Phase 3)
Arthroplasty, Replacement, Knee (Phase 2)
Aspirin (Phase 4)
Asthma (Phase 3)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 2)
Bacterial Infections (Phase 4)
Bariatric Surgery (Phase 4)
Barrett Esophagus (Phase 4)
Bile Reflux (Phase 4)
Bone and Bones (Phase 1)
Breast Neoplasms (Phase 2)
Chest Pain (Phase 3)
Colorectal Neoplasms (Phase 4)
Coronary Artery Disease (Phase 4)
Cough (Phase 4)
Critical Illness (Phase 4)
Cystic Fibrosis (Phase 2)
Cytochrome P-450 CYP2C19 (Phase 4)
Deglutition Disorders (Phase 2)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 3)
Disease Eradication (Phase 1)
Drug Misuse (Phase 4)
Drug Resistance, Bacterial (Phase 3)
Drugs, Generic (Phase 1)
Drugs, Investigational (Phase 1)
Drug Therapy (Phase 4)
Dry Eye Syndromes (Phase 3)
Duodenal Ulcer (Phase 3)
Dyspepsia (Phase 4)
Eosinophilic Esophagitis (Phase 2/Phase 3)
Esophageal Neoplasms (Phase 3)
Esophagitis (Phase 4)
Esophagitis, Peptic (Phase 4)
Estradiol (Phase 2/Phase 3)
Fasting (Phase 1)
Gastric Acid (Phase 3)
Gastritis (Phase 4)
Gastritis, Atrophic (Phase 4)
Gastrointestinal Diseases (Phase 3)
Gastrointestinal Hemorrhage (Phase 3)
Gastrointestinal Stromal Tumors (Phase 4)
General Surgery (Phase 4)
Gram-Negative Bacterial Infections (Phase 2)
Graves Ophthalmopathy (Phase 3)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 4)
Heartburn (Phase 4)
Helicobacter (Phase 4)
Helicobacter Infections (Phase 4)
Helicobacter pylori (Phase 4)
Hemorrhage (Phase 4)
Hepatitis B, Chronic (Phase 1)
HIV (Phase 3)
Homeostasis (Phase 1)
Hot Flashes (Phase 1)
Hypertension, Portal (Phase 4)
Hypertension, Pulmonary (Phase 1)
Ileostomy (Phase 1/Phase 2)
Inflammation (Phase 3)
Intestinal Neoplasms (Phase 4)
Joint Diseases (Phase 2)
Laryngeal Diseases (Phase 3)
Laryngitis (Phase 4)
Laryngopharyngeal Reflux (Phase 4)
Liver Cirrhosis (Phase 4)
Low Back Pain (Phase 3)
Lung Diseases (Phase 3)
Lung Diseases, Obstructive (Phase 3)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 1)
Medicine, Chinese Traditional (Phase 1)
Multiple Sclerosis, Relapsing-Remitting (Phase 4)
Myocardial Infarction (Phase 4)
Nausea (Phase 4)
Neoplasm Metastasis (Phase 2)
Neoplasms (Phase 1)
Neuralgia (Phase 2)
Obesity, Morbid (Phase 4)
Osteoarthritis (Phase 4)
Osteoporosis (Phase 4)
Pain (Phase 4)
Pancreatitis, Chronic (Phase 1)
Peptic Ulcer (Phase 4)
Peptic Ulcer Hemorrhage (Phase 4)
Percutaneous Coronary Intervention (Phase 3)
Pharmacokinetics (Phase 1)
Pharmacology (Phase 1)
Platelet Aggregation Inhibitors (Phase 1)
Precancerous Conditions (Phase 3)
Pre-Eclampsia (Phase 3)
Premature Birth (Phase 1)
Proton Pump Inhibitors (Phase 4)
Psoriasis (Phase 4)
Pulmonary Arterial Hypertension (Phase 1)
Radiodermatitis (Phase 1/Phase 2)
Respiratory Aspiration (Phase 4)
Schizophrenia (Phase 4)
Sepsis (Phase 3)
Shock, Septic (Phase 3)
Signs and Symptoms (Phase 3)
Signs and Symptoms, Digestive (Phase 3)
Sleep Disorders, Intrinsic (Phase 4)
Stomach Diseases (Phase 4)
Stomach Neoplasms (Phase 4)
Stomach Ulcer (Phase 4)
Therapeutic Equivalency (Phase 1)
Tooth Abnormalities (Phase 4)
Tooth Erosion (Phase 1/Phase 2)
Ulcer (Phase 4)
Vasomotor System (Phase 1)
Vomiting (Phase 4)
Voriconazole (Phase 1)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
